1. Introduction
===============

Vitamin B~12~, or cobalamin (Cbl), is an organometallic cofactor that supports the activities of enzymes in organisms, ranging from bacteria to humans \[[@B1-metabolites-03-00144],[@B2-metabolites-03-00144]\]. In animals, Cbl is the cofactor for cytosolic methionine synthase (EC 2.1.1.13) and mitochondrial methylmalonyl-CoA mutase (MCM, EC 5.4.99.2), more specifically, methylcobalamin (MeCbl) and 5′-deoxyadenosylcobalamin (AdoCbl), respectively. Inhibition of Cbl transport or biochemical modifications of Cbl usually causes severe diseases \[[@B3-metabolites-03-00144]\]. The *cblA* complementation class of inborn errors of Cbl metabolism is one of three known disorders that affect AdoCbl synthesis without affecting the synthesis of MeCbl \[[@B4-metabolites-03-00144]\]. The gene responsible for *cblA* has been identified through the examination of prokaryotic gene arrangements and is called *MMAA* \[[@B3-metabolites-03-00144]\]. The deduced amino acid sequences of human or mouse MMAA show homology with the periplasmic protein kinase ArgK of *Escherichia coli* \[[@B3-metabolites-03-00144]\]. ArgK is a coupled ATPase of the lysine, arginine and ornithine (LAO) transport system \[[@B5-metabolites-03-00144]\], suggesting the possibility that MMAA is a component of a transporter or an accessory protein that is involved in the translocation of Cbl into mitochondria \[[@B3-metabolites-03-00144]\].

MCM and a homolog of *MMAA* (*MeaB*) are present in the genome of the methylotrophic bacterium *Methylobacterium extorquens* AM1 \[[@B6-metabolites-03-00144]\]. This bacterium synthesizes AdoCbl and utilizes AdoCbl as the cofactor for MCM and *meaA* (ethylmalonyl-CoA mutase). The mutation in *meaB* has no effect on the function of *meaA*. However, total MCM activity was significantly reduced in *meaB* mutants compared with that of the wild-type, although the *meaB* mutants synthesized AdoCbl \[[@B7-metabolites-03-00144]\]. These findings suggest that *meaB* is not involved in the biosynthesis of AdoCbl or the transport of Cbl in *M. extorquens*.

Diol and glycerol dehydratases, Cbl-dependent enzymes, undergo concomitant irreversible inactivation by glycerol during catalysis \[[@B8-metabolites-03-00144]\]. This inactivation involves irreversible cleavage of the Co-C bond of AdoCbl, forming 5′-deoxyadenosine and an alkylcobalamin-like species. The Cbl species that is formed remains tightly bound to the enzyme, inactivating the enzyme irreversibly. Diol or glycerol dehydratase-reactivating factor participates in reactivation of the inactivated holoenzymes by mediating ATP-dependent exchange of the modified coenzyme for free intact coenzyme \[[@B9-metabolites-03-00144],[@B10-metabolites-03-00144],[@B11-metabolites-03-00144],[@B12-metabolites-03-00144]\].

Korokova and Lidstrom \[[@B7-metabolites-03-00144]\] found that *meaB* forms a complex with MCM and stimulates MCM activity *in vitro*. However, neither cyanocobalamin (CNCbl) nor AdoCbl is released from MCM in the presence of *meaB*. Further, purified *meaB* did not restore MCM activity in the extracts prepared from the *meaB* mutant. Therefore, they proposed that *meaB* does not function as a reactivating factor, but is involved in protection of MCM from suicide inactivation by possibly providing a stabilization function. However, recently, it has been reported that *meaB* involved in AdoCbl trafficking to MCM functions as an editor, discriminating between inactive and active cofactor forms and permitting transfer only of AdoCbl, in a process that is gated by GTP hydrolysis \[[@B13-metabolites-03-00144]\]. Furthermore, the editing function of *meaB* is also used for reactivating inactivated MCM formed occasionally during turnover. Takahashi-Íñiguez *et al.* \[[@B14-metabolites-03-00144]\] have reported that human *MMAA* plays as two important roles as both the "protectase" and reactivase of MCM. In *E. coli*, sleeping beauty mutase (sbm; MCM homolog) interacts with *ygfD* (the *MMAA* or *meaB* homolog) \[[@B15-metabolites-03-00144]\].

*Euglena gracilis* Z, a photosynthetic flagellate, possesses characteristics of both plant and animal cells \[[@B16-metabolites-03-00144]\] and requires Cbl for its growth \[[@B17-metabolites-03-00144],[@B18-metabolites-03-00144]\]. It has been reported that *E. gracilis* has Cbl-dependent methionine synthase and ribonucleotide redactase \[[@B19-metabolites-03-00144],[@B20-metabolites-03-00144]\]. Furthermore, the purification of aquacobalamin reductase form *E. gracilis* was reported \[[@B21-metabolites-03-00144]\]. Recently, we reported that *E. gracilis* MCM is a homodimer and is present in mitochondria \[[@B22-metabolites-03-00144]\]. Further, we isolated a full-length *E. gracilis* MCM cDNA whose deduced amino acid sequence indicates that it is a mitochondrial protein. These findings suggest the possibility that *E. gracilis*, human and *M. extorquens* MCMs share molecular properties. To explore the function of *MMAA*, we isolated a cDNA encoding *MMAA* from *E. gracilis* and measured MCM activity in *E. coli* that expressed MCM alone or together with *MMAA.*

2. Results and Discussion
=========================

2.1. Isolation and Characterization of a cDNA Encoding *MMAA*
-------------------------------------------------------------

To isolate a cDNA encoding *E. gracilis MMAA*, a BLASTP search was performed against the *Euglena* EST data base \[[@B23-metabolites-03-00144]\] using the amino acid sequence of human *MMAA* \[[@B3-metabolites-03-00144]\] as a query. This search revealed an EST clone (cluster ID ELL00001639) encoding a putative *E. gracilis MMAA*. Similar to other *MMAA* or *meaB*, this EST clone is annotated as a putative periplasmic protein kinase ArgK. The corresponding full-length cDNA was cloned using the rapid amplification of cDNA ends method, and its sequence was submitted to the DDBJ/GenBank/EMBL data base (accession number AB772316). In *E. gracilis*, the short sequences present at the 5′ end of small cytoplasmic mRNAs \[[@B24-metabolites-03-00144],[@B25-metabolites-03-00144],[@B26-metabolites-03-00144]\] are transferred to pre-mature mRNAs by a *trans*-splicing mechanism. The presence of a spliced leader sequence at the 5′ end of *E. gracilis MMAA* cDNA (5′-TTTTTTTTCG-3′) indicated that full-length *MMAA* cDNA was obtained. The cDNA contains 1,400 bp with an open reading frame of 1,056 bp predicted to encode 352 amino acids residues (with a calculated molecular mass of 39113.9 Da).

The deduced amino acid sequence of the *E. gracilis MMAA* cDNA shows 79%, 79%, 79% and 80% similarity to human (NP_758454), mouse (NP_598584), *Danio rerio* (NP_001098582) *MMAAs* and *M. extorquens* (AAL86727) *meaB*, respectively ([Figure 1](#metabolites-03-00144-f001){ref-type="fig"}). The *E. gracilis MMAA* cDNA encodes a predicted protein of 352 amino acid residues and includes Walker A and Walker B motifs, as well as a GTP-binding sequence \[[@B3-metabolites-03-00144]\]. The presence of a signal peptide and cleavage sites was predicted by the TargetP prediction program \[[@B27-metabolites-03-00144]\]. However, the cleavage site is present in the relatively well-conserved region among the *MMAAs* of vertebrates ([Figure 1](#metabolites-03-00144-f001){ref-type="fig"}), suggesting the possibility that the *MMAA* cleavage site in *E. gracilis* is located closer to its N-terminal region.

2.2. Expression of MMAA by E. gracilis
--------------------------------------

Although it is known that the levels of MCM protein and total MCM activity in the livers of Cbl-deficient rats are higher than those in the livers of rats whose diet was supplemented with Cbl, the level of the MCM transcript in the livers of rats fed a Cbl-deficient diet was lower than that in the livers of rats fed Cbl-supplemented diets \[[@B28-metabolites-03-00144]\]. To explore the regulation of the expression of *MCM* and *MMAA*, we analyzed the levels of their respective transcripts in response to Cbl in Cbl-deficient *E. gracilis*.

Cells cultured (1 mL) for one week were transferred to CNCbl-free medium, cultured for another week and then transferred (1 mL) to CNCbl-free medium. After three days, CNCbl (5 µg/mL) was added, and the cells were cultured for another three days (closed circles; [Figure 2](#metabolites-03-00144-f002){ref-type="fig"}). Under the Cbl deficient condition, the growth of *E. gracilis* cells was highly suppressed (open circles; [Figure 2](#metabolites-03-00144-f002){ref-type="fig"}). The addition of CNCbl increased the cell growth.

![Comparison of the deduced amino acid sequences of *MMAA* from *E. gracilis*, human, mouse, *D. rerio* and *meaB* from *M. extorquens*. Sequences were aligned using ClustalW \[[@B29-metabolites-03-00144]\]. Sequence motifs defining the G3E family of proteins are indicated, including the GxxGxGK\[S/T\] Walker A and the DHbHbHbHbE Walker B motif. Hb denotes hydrophobic residues and an \[N/T\]KxD GTP-binding motif, as described by Leipe *et al.* \[[@B30-metabolites-03-00144]\], is underlined. Red letters indicate the mitochondrial leader sequence. Amino acids that are identical in all species are shaded gray.](metabolites-03-00144-g001){#metabolites-03-00144-f001}

![Effect of the addition of CNCbl on the growth of Cbl-deficient *E. gracilis* cells. Open circles are Cbl-deficient cells. Closed circles are Cbl-supplemented cells. The data are the mean value ± SD of three individual experiments. Asterisks indicate that the mean values are significantly different compared with those of Cbl-deficient *E. gracilis* cells (*p* \< 0.05).](metabolites-03-00144-g002){#metabolites-03-00144-f002}

In three-day cultured Cbl-deficient *E. gracilis* cells, total MCM activity was 8.54 nmol min^−1^ mg^−1^ protein. At three days after the addition of Cbl to Cbl-deficient cells, total MCM activity was decreased to 38%, while that in the Cbl-deficient cells remained high (89%). In Cbl-deficient *E. gracilis* cells, the level of the *MCM* transcript was 2.3-fold higher than that in the Cbl-supplemented *E. gracilis* cells ([Figure 3](#metabolites-03-00144-f003){ref-type="fig"}).

In contrast, no significant differences in the levels of the *MMAA* transcript were observed between the Cbl-deficient and Cbl-supplemented *E. gracilis*, suggesting the possibility that *MMAA* is constitutively expressed these cells.

![Semi-quantitative real-time (RT)-PCR analysis of the levels of *MCM* and *MMAA* transcripts in (1) Cbl-deficient and (2) Cbl-supplemented *E. gracilis* cultures. Fragments corresponding to *MCM*, *MMAA*, and *EF1-α* were amplified using PCR.](metabolites-03-00144-g003){#metabolites-03-00144-f003}

2.3. Effect of Coexpression of *MMAA* on *MCM* Activity in E. coli
------------------------------------------------------------------

As noted above, *MCM* activity is significantly decreased in *meaB* mutants of *M. extorquens* \[[@B7-metabolites-03-00144]\]. To examine the effect of the expression of *MMAA* on *MCM* activity, the expression vectors pET/Eg.MCM and pCDF/Eg.MMAA were transformed together or individually in *E. coli* using the expression vectors described below*.* In cells transformed with either the combinations of pET-16b and pCDF/Eg.MMAA or pET-16b and pCDF-1b, *MCM* activity was below the detection limit of the assay (5 pmol min^−1^ mg^−1^ protein) ([Table 1](#metabolites-03-00144-t001){ref-type="table"}). No significant difference in *MCM* activity was detected between cells expressing *MCM* alone or together with *MMAA .* We checked *E. gracilis* MMAA protein in *E. coli* cells using anti His-tag antibody. *E. gracilis* MMAA protein was slightly expressed in the soluble fraction in the pCDF-1b/Eg.MMAA transformed *E. coli*, suggesting that the expression level of *E. gracilis* MMAA protein was very low.

metabolites-03-00144-t001_Table 1

###### 

*MCM* activity in *E. coli* expressing *MCM* or *MMAA* together or individually.

  Vector pairs                MCM activity (nmol min^−1^ mg^−1^ protein)
  --------------------------- --------------------------------------------
  pET/Eg.MCM - pCDF-1b        12.1 ± 2.0
  pET-16b - pCDF-1b/Eg.MMAA   \< 0.005
  pET-16b - pCDF-1b           \< 0.005
  pET/Eg.MCM - pCDF/Eg.MMAA   11.6 ± 1.8

Data are mean values ± standard deviation from three assays.

*E. coli* *sbm* and *ygfD* genes are contained in an operon comprising *sbm-ygfD-ygfG-ygfH* \[[@B31-metabolites-03-00144]\]. *E. coli sbm* forms a homodimer \[[@B14-metabolites-03-00144]\] as its *E. gracilis* homolog. Further, the deduced amino acid sequence of *E. coli sbm* is 89% similar to that of *E. gracilis MCM*. These findings suggest the possibility that *ygfD* functions to protect *E. gracilis MCM* from inactivation and acts to reactivate it in *E. coli*. Previous findings, and our presented data suggests the possibility that the function of *E. gracilis* *MMAA* was similar to those of human *MMAA* and *meaB*.

In *Caenorhabditis elegans*, the suppression of *MMAA*, *MMAB* \[co(I)balamin adenosyltransferase\] or *MCM* expression using RNAi technology caused the increase of methylmalonic acid \[[@B32-metabolites-03-00144]\]. To clarify the Cbl metabolism, including the function of *MMAA* in *E. gracilis*, analyses using recombinant proteins and RNAi technology are necessary.

3. Experimental Section
=======================

3.1. E. gracilis and Culture Conditions
---------------------------------------

*E. gracilis* strain *Z* was grown in Koren--Hutner medium under continuous illumination at a photosynthetic photon flux density of 24 µmol m^−2^ s^−1^ at 26 °C until the cells reached stationary phase (6 days) \[[@B33-metabolites-03-00144]\]

3.2. RT-PCR-Amplification and Sequence Analysis
-----------------------------------------------

Based on analysis of the *Euglena* EST database using the Protest EST Program \[[@B23-metabolites-03-00144]\], a gene-specific primer was designed to amplify the missing 3′ and 5′ ends of the *MMAA* EST sequence (ELL00001639). Total RNA was isolated from *E. gracilis* using Sepasol-RNA I (Nakalai Tesque, Kyoto, Japan). The primers 5′-TGGTGGAGTCAAACCACATG-3′ and 5′- TCAGACACTTCCACAATGCC -3′ were used sequentially for 3′-rapid amplification of cDNA ends (3′-RACE) or 5′-RACE with a GeneRacer^TM^ Kit (Life Technologies, Carlsbad, CA, USA). Amplified fragments were cloned into pSTBlue-1, and the nucleotide sequences of the 3′- or 5′-extended fragments were determined using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). The full-length coding sequence of *Euglena MMAA* was amplified using PCR primed by Eg.MMAA-F (5′-ATTCCATGCAACGCCGCCCA-3′) and Eg.MMAA-R (5′-CCACGTATGCTTTCCTCCTT-3′). PCR amplification was carried out using PrimeSTAR (Takara Shuzo, Kyoto, Japan). A single-stranded cDNA prepared from 3-day *Euglena* cultures was used as template. The amplified product was cloned into pZErO-2 (Life Technologies), and the sequence was verified using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems).

3.3. Semi-Quantitative RT-PCR Analysis
--------------------------------------

Semi*-*quantitative RT-PCR analysis was performed according to Ishikawa *et al.* \[[@B22-metabolites-03-00144]\]. Primer pairs were as follows: EF1-α-F (5′-GTTGACCCTCATTGGTGCTT-3′); EF1-α-R (5′-CTTGGTCACCTTCCCAGTGT-3′); Eg.MCM-F (5′-GTCCATCGACAACACCATTG -3′); Eg.MCM-R (5′-CGACTTCAGCTCGTTGATGA -3′); and Eg.MMAA-F (5′-ATTCCATGCAACGCCGCCCA-3′); Eg.MMAA-R (5′-TCAGACACTTCCACAATGCC-3′). The experiments were repeated at least three times with cDNA prepared from three batches of *E. gracilis* cultures. The quantitative intensity was determined by applying densitometry to images of the blots \[[@B34-metabolites-03-00144]\].

3.4. Construction of *MMAA* and *MCM* Expression Plasmids
---------------------------------------------------------

To construct *MMAA* and *MCM* expression vectors, their open reading frames were amplified from the first strand cDNAs, using the primer sets as follows: MMAA-*Pma* CI-F (5′-TCACCACCACCATCACGTGATGCAACGCCGCCCATGCAA-3′), MMAA-*Pma* CI-R (5′-TCGAACCGGTACCCACGTGCTACAGGCTGCAGCCCTCCA-3′), MCM-*Nde* I-F (5′-CATATGATCGACCTTCCACCAAAGTG-3′) and MCM-*Bam* HI-F(5′-GGATCCTCAGAGTTTGTTCAGGACCT-3′). The amplified DNA fragments were ligated into the vector pZErO-2 (Life Technologies), and the sequence was verified using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems). The resulting constructs were digested with *Pma* CI for *MMAA* or *Nde* I/*Bam* HI for *MCM* and ligated into the expression vectors pCDF-1b (Novagen, Madison, WI) or pET16b (Novagen) to produce histidine-tagged proteins. The resulting constructs were designated pCDF/Eg.MMAA and pET/Eg.MCM, respectively.

3.5. Expression of Recombinant MMAA or MCM Proteins
---------------------------------------------------

To explore the effect of the expression of Eg.MMAA on MCA activity in *E. coli*, four plasmids sets (pET16-b and pCDF-1b, pET/Eg.MCM and pCDF-1b, pET16-b and pCDF/Eg.MMAA and pET/Eg.MCM and pCDF/Eg.MMAA) were introduced into *E. coli* strain BL21 Star (DE3) (Life Technologies). Transformed *E. coli* were cultured in 50 mL LB medium supplemented with ampicillin (50 µg mL^−1^) and chloramphenicol (34 µg mL^−1^) at 37 °C overnight. The culture was then transferred to Luria--Bertani medium (1 l). When the culture reached an absorbance of 0.6 at 600 nm, 0.4 mM isopropyl β-D-thiogalactopyranoside was added, and the bacteria were grown for another 6 h at 37 °C. The cells were harvested by centrifugation at 6,000 × *g* for 10 min, and the pellets were kept frozen at −20 °C.

3.6. Enzyme Extraction and Assay
--------------------------------

*E. coli* pellets were resuspended in 100 mM Tris-HCl, pH 7.5, sonicated (Tomy, Tokyo, Japan) (10 kHz) using 20 s strokes with 30 s intervals and centrifuged at 15,000 × g for 15 min. *MCM* activity was assayed by a modified HPLC method described by Gaire *et al.* (1999). Briefly, the assay mixture (0.15 mL) for determining total *MCM* activity contained 100 mM potassium phosphate buffer (pH 7.5), 30 µM AdoCbl, 0.15 mM (*R, S*)-methylmalonyl-CoA and enzyme. The components, except for (*R, S*)-methylmalonyl-CoA, were mixed in microcentrifuge tubes in the dark, and the temperature was equilibrated by incubation in a heating bucket (e-Heating Bucket EHB, TAITEC Cop., Saitama, Japan) maintained at 3 °C. The reaction mixture was preincubated for 5 min, and the reaction was started by the addition of (*R, S*)-methylmalonyl-CoA and maintained for 5 min. The enzyme reaction was stopped by the addition of 50 µL of 10% (w/v) trichloroacetic acid. The reaction mixture was filtered through a 0.45 µM membrane filter (Millex Syringe Driven Filter Unit, LH-type, Milli-pore, USA). An aliquot (20 µL) of the filtrate was analyzed using a Shimadzu HPLC apparatus (two LC-10ADvp pumps, DGV-12A degasser, SCL-10Avp system controller, SPD-10Avvp ultraviolet-visible detector, CTO-10Avp column oven, 100 µL sample loop and C-R6A Chromatopac Integrator). The sample (20 µL) was loaded onto a reversed-phase HPLC column (Cosmosil 5C18-AR-II, Φ3.0 × 150 mm) equilibrated with 50% solvent A (100 mM acetic acid in 100 mM potassium phosphate buffer, pH 7.0) and 50% solvent B \[18% (v/v) methanol in solvent A\]. (*R, S*)-methylmalonyl-CoA and succinyl-CoA were eluted with a linear gradient of methanol (50%--100% solvent B) for 7.0 min at 40 °C and monitored by measuring the absorbance at 254 nm. The flow rate was 1.0 mL min^−1^. *MCM* activity was calculated from the amount of succinyl-CoA formed. Protein concentrations were determination using a Quant-iT™ Protein Assay and a Qubit fluorometer (Life Technologies).

4. Conclusion
=============

*E. gracilis MMAA* cDNA contained an open reading frame encoding the protein of 352 amino acids with a calculated molecular mass of 39113.9 Da, preceded by a putative mitochondrial targeting signal consisting of 41 amino acid residues. No significant differences in the levels of the *MMAA* transcript were observed between the Cbl-deficient and Cbl-supplemented *E. gracilis*. No significant difference in MCM activity was observed between *E. coli* that expressed either MCM together with MMAA or expressed MCM alone. Previous findings, and our presented data suggests the possibility that the function of *E. gracilis* *MMAA* was similar to those of human *MMAA* and *meaB*.
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